Autor segons l'article: Parra, S; Cabré, A; Marimon, F; Ferré, R; Ribalta, J; Gonzàlez, M; Heras, M; Castro, A; Masana, L
Departament: Medicina i Cirurgia
Autor/s de la URV: CABRÉ LLOBET, ANNA / Castro Salomó, Antoni / FERRÉ VALLÈS, RAIMON / HERAS IBAÑEZ, MERCEDES / Marimon Cortes, Francesc / Masana Marín, Luis / Parra Pérez, Sandra / Ribalta Vives, Josep
Paraules clau: Systemic lupus erythematosus Haematologic Changes Cardiovascular disease systemic lupus erythematosus changes cardiovascular disease
Resum: The aim of this study is to determine if circulating fatty acid-binding protein 4 (FABP4) plasma levels are a possible marker of metabolic risk in SLE patients. Circulating levels of adipose FABP4 are associated with adiposity, insulin resistance (IR), metabolic syndrome, diabetes and cardiovascular diseases. Patients affected by systemic lupus erythematosus (SLE) show an accelerated atherosclerosis that cannot be entirely explained by traditional cardiovascular risk factors. Sixty consecutive patients with SLE and 34 non-SLE age-matched controls were recruited for the study. Total plasma lipids and circulating FABP4 were determined. Subclinical atherosclerosis was evaluated by measuring carotid intimae-media thickness (c-IMT) by sonography, and the distribution of lipoprotein subclasses was analysed by nuclear magnetic resonance (NMR) spectroscopy. In the SLE group, FABP4 was associated with IR, atherogenic dyslipidaemia, as measured by NMR, and the presence of subclinical atherosclerosis. In multivariate analyses FABP4 was associated with increased c-IMT independent of the inflammatory state of the patient. In sum, circulating FABP4 is involved in the metabolic disturbances of SLE affecting lipid metabolism and IR, and it could be a biomarker of atherosclerosis in this population.
Àrees temàtiques: Zootecnia / recursos pesqueiros Saúde coletiva Rheumatology Odontología Nutrição Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Farmacia Educação física Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Biotecnología Antropologia / arqueologia
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 09612033
Adreça de correu electrònic de l'autor: francesc.marimon@urv.cat sandra.parra@urv.cat antoni.castro@urv.cat luis.masana@urv.cat josep.ribalta@urv.cat
Identificador de l'autor: 0000-0001-9363-6574 0000-0001-5441-6333 0000-0002-0789-4954 0000-0002-8879-4719
Data d'alta del registre: 2024-09-07
Versió de l'article dipositat: info:eu-repo/semantics/submittedVersion
Enllaç font original: https://journals.sagepub.com/doi/10.1177/0961203313517405
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Lupus. 23 (3): 245-254
Referència de l'ítem segons les normes APA: Parra, S; Cabré, A; Marimon, F; Ferré, R; Ribalta, J; Gonzàlez, M; Heras, M; Castro, A; Masana, L (2014). Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients. Lupus, 23(3), 245-254. DOI: 10.1177/0961203313517405
DOI de l'article: 10.1177/0961203313517405
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2014
Tipus de publicació: Journal Publications